End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17,110 KRW | -1.21% | +0.41% | -12.66% |
Jan. 08 | CHA Biotech to Partner with Subsidiary to Advance NK Cell Therapy | MT |
2023 | CHA Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2022 | 845B 615M | Sales 2023 | 954B 694M | Capitalization | 1,103B 803M |
---|---|---|---|---|---|
Net income 2022 | -47.54B -34.61M | Net income 2023 | -8.43B -6.14M | EV / Sales 2022 | 1.13 x |
Net Debt 2022 | 225B 164M | Net Debt 2023 | 228B 166M | EV / Sales 2023 | 1.4 x |
P/E ratio 2022 |
-15.4
x | P/E ratio 2023 |
-112
x | Employees | 312 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.17% |
1 day | -1.21% | ||
1 week | +0.41% | ||
Current month | -12.08% | ||
1 month | -12.08% | ||
3 months | -2.89% | ||
6 months | +6.14% | ||
Current year | -12.66% |
Managers | Title | Age | Since |
---|---|---|---|
Sang-Hoon Oh
CEO | Chief Executive Officer | 60 | 19-02-28 |
Dong-Joon Lee
DFI | Director of Finance/CFO | 53 | 19-03-31 |
Jong-Guk Song
PSD | President | 63 | 05-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sang-kyu Lee
BRD | Director/Board Member | 72 | - |
Jong-Guk Song
PSD | President | 63 | 05-12-31 |
Joong-Ho Kim
BRD | Director/Board Member | 81 | 08-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 2 M€ | -.--% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | -0.14% | - | |
0.00% | 34 M€ | +1.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 17,030 | -0.47% | 106,242 |
24-04-30 | 17,110 | -1.21% | 149,251 |
24-04-29 | 17,320 | +2.49% | 169,394 |
24-04-26 | 16,900 | -0.65% | 154,683 |
24-04-25 | 17,010 | -1.05% | 109,477 |
End-of-day quote Korea S.E., April 29, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-12.66% | 696M | |
+12.08% | 42.68B | |
+0.67% | 42.4B | |
+46.96% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- A085660 Stock